Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection
Infection and Immunity · 12.11.2024 · 92 (11)
DOI: 10.1128/iai.00345-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 12.11.2024. Verfasst von Rebecca S Dookie und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United King…. Hauptthemen laut MEDLINE: Plasmodium yoelii, Receptors, Immunologic, B7-H1 Antigen, Malaria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust (WT), UKRI | Medical Research Council (MRC).
Abstract (Originalsprache)
Pro-inflammatory immune responses are rapidly suppressed during blood-stage malaria but the molecular mechanisms driving this regulation are still incompletely understood. In this study, we show that the co-inhibitory receptors TIGIT and PD-1 are upregulated and co-expressed by antigen-specific CD4 + T cells (ovalbumin-specific OT-II cells) during non-lethal Plasmodium yoelii expressing ovalbumin ( Py NL -OVA ) blood-stage infection. Synergistic blockade of TIGIT and PD-L1, but not individual blockade of each receptor, during the early stages of infection significantly improved parasite control during the peak stages (days 10–15) of infection. Mechanistically, this protection was correlated with significantly increased plasma levels of IFN-γ, TNF, and IL-2, and an increase in the frequencies of IFN-γ-producing antigen-specific T-bet + CD4 + T cells (OT-II cells), but not antigen-specific CD8 + T cells (OT-I cells), along with expansion of the splenic red pulp and monocyte-derived macrophage populations. Collectively, our study identifies a novel role for TIGIT in combination with the PD1-PD-L1 axis in regulating specific components of the pro-inflammatory immune response and restricting parasite control during the acute stages of blood-stage Py NL infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
- The Jenner Institute, University of Oxford, Oxford, United Kingdom.
- Leiden Malaria Group, Center of Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
- Department of Cancer Immunology, Genentech, South San Francisco, California, USA.
ORCID-Profile: Simon J Draper, Kevin N Couper
Förderung
- Wellcome Trust (WT)
- UKRI | Medical Research Council (MRC)
Zitieren
APA
Dookie, R. S., Villegas-Mendez, A., Cheeseman, A., Jones, A. P., Barroso, R., Barrett, J. R., Draper, S. J., Janse, C. J., Grogan, J. L., MacDonald, A. S., & Couper, K. N. (2024). Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection. Infection and Immunity, 92(11). https://doi.org/10.1128/iai.00345-24
Vancouver
Dookie RS, Villegas-Mendez A, Cheeseman A, Jones AP, Barroso R, Barrett JR, et al. Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection. Infection and Immunity. 2024;92(11). doi:10.1128/iai.00345-24
BibTeX
@article{Dookie2024,
author = {Dookie, Rebecca S and Villegas-Mendez, Ana and Cheeseman, Antonn and Jones, Adam P and Barroso, Ruben and Barrett, Jordan R and Draper, Simon J and Janse, Chris J and Grogan, Jane L and MacDonald, Andrew S and Couper, Kevin N},
title = {Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection},
journal = {Infection and Immunity},
year = {2024},
volume = {92},
number = {11},
doi = {10.1128/iai.00345-24}
}
EUVIMED